Tumor-Associated CD75s- And Iso-CD75s-Gangliosides Are Potential Targets for Adjuvant Therapy in Pancreatic Cancer

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-08-0353
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Current Status of Adjuvant Therapy for Pancreatic Cancer

Oncologist
Cancer ResearchMedicineOncology
2010English

Molecular Machineries of pH Dysregulation in Tumor Microenvironment: Potential Targets for Cancer Therapy

BioImpacts
BiochemistryMedicineGeneticsMolecular BiologyPharmaceutical Science
2017English

Tumor Stroma as Targets for Cancer Therapy

Pharmacology and Therapeutics
Pharmacology
2013English

Peroxisome-Proliferator-Activated Receptors (PPARs) Are Potential Drug Targets for Cancer Therapy

Oncotarget
Oncology
2017English

Neo-Adjuvant Cheomoradiation Therapy for Pancreatic Cancer Is Associated With Adverse Outcome After Pancreaticoduodectomy.

HPB
HepatologyGastroenterology
2018English

Class I and Class II Histone Deacetylases Are Potential Therapeutic Targets for Treating Pancreatic Cancer

PLoS ONE
Multidisciplinary
2012English

Multiagent Neoadjuvant Chemotherapy and Tumor Response Are Associated With Improved Survival in Pancreatic Cancer

HPB
HepatologyGastroenterology
2019English

Actionable Intelligence Provided by Pancreatic Cancer Genomic Landscape: Are Targets for Curative Therapy on the Map?

Translational Cancer Research
Cancer ResearchOncologyRadiologyNuclear MedicineImaging
2016English

Personalized Medicine in Pancreatic Cancer: Prognosis and Potential Implications for Therapy

Journal of Gastrointestinal Surgery
SurgeryGastroenterology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy